9 Amazing Things We’ve Achieved in 2017 With Help From CRISPR – ScienceAlert
Science News Magazine |
9 Amazing Things We’ve Achieved in 2017 With Help From CRISPR
ScienceAlert CRISPR has been used to successfully target the ‘command centre’ of cancer – the hybrid fusion genes that often trigger abnormal tumour growths. By cutting and pasting, researchers created a cancer-busting gene that actually shrunk tumours in mice … Resistance to CRISPR gene drives may arise easilyScience News Magazine Researchers Design, Construct Genome-Wide Sequence-Verified Arrayed CRISPR LibraryGenomeWeb Library of CRISPR targeting sequences increases power of the gene-editing methodEurekAlert (press release) Technology Networks –Digital Journal –Xinhua all 13 news articles » |
Science News Magazine |
9 Amazing Things We’ve Achieved in 2017 With Help From CRISPR
ScienceAlert CRISPR has been used to successfully target the ‘command centre’ of cancer – the hybrid fusion genes that often trigger abnormal tumour growths. By cutting and pasting, researchers created a cancer-busting gene that actually shrunk tumours in mice … Resistance to CRISPR gene drives may arise easilyScience News Magazine Researchers Design, Construct Genome-Wide Sequence-Verified …GenomeWeb Library of CRISPR targeting sequences increases power of the gene …EurekAlert (press release) Xinhua –The Economist –Genetic Engineering & Biotechnology News all 12 news articles » |
|
SillaJen : China’s FDA Oks To Commence Phase 3 Trial For Oncolytic Immunotherapy
Nasdaq (RTTNews.com) – SillaJen, Inc. and Lee’s Pharmaceutical Holdings Ltd. announced approval by the China Food and Drug Administration to conduct a Phase 3 clinical trial for advanced liver cancer using its oncolytic immunotherapy called Pexa-Vec (formerly … |
|
SillaJen : China’s FDA Oks To Commence Phase 3 Trial For Oncolytic Immunotherapy
Nasdaq (RTTNews.com) – SillaJen, Inc. and Lee’s Pharmaceutical Holdings Ltd. announced approval by the China Food and Drug Administration to conduct a Phase 3 clinical trial for advanced liver cancer using its oncolytic immunotherapy called Pexa-Vec (formerly … |
|
CIRM Approves $5.8 Million Grant for CAR–T Therapy That Targets Cancer Stem Cells
Newswise (press release) Newswise — The Independent Citizens Oversight Committee of the California Institute for Regenerative Medicine (CIRM) today unanimously approved a $5.8 million award to University of California San Diego School of Medicine researchers to develop a … |
PBS NewsHour |
Will we be wiped out by machine overlords? Maybe we need a game plan now
PBS NewsHour NICK BOSTROM: The greatest existential risks arise from certain anticipated technological breakthroughs that we might make, in particular, machine superintelligence, nanotechnology, and synthetic biology, fundamentally because we don’t have the ability … |
Sacramento Bee |
California stem cell agency researching cures for brain cancer afflicting McCain
Sacramento Bee The aggressive brain cancer that now afflicts U.S. Sen. John McCain has long been a target of California’s $3 billion stem cell agency. During its 12-year life span, the agency, formally known as the California Institute for Regenerative Medicine, or … |
Sacramento Bee |
California stem cell agency researching cures for brain cancer afflicting McCain
Sacramento Bee The aggressive brain cancer that now afflicts U.S. Sen. John McCain has long been a target of California’s $3 billion stem cell agency. During its 12-year life span, the agency, formally known as the California Institute for Regenerative Medicine, or … |